BackReShape Lifesciences Overview

ReShape Lifesciences Profit Margin

Profitability ratio analysis for RSLS.

Quarterly Profit Margin

-3119.63%
↓ 2455.59% YoY

As of Mar 2026

Annual Profit Margin (TTM)

1539.01%
↑ 3288.67% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin